We have located links that may give you full text access.
Stem Cell Markers (Cytokeratin 17 and Cytokeratin 19) in Scarring and Nonscarring Alopecia.
BACKGROUND: Alopecia is one of the most important hair follicle (HF) disorders, which is divided into scarring (cicatricial) and nonscarring (noncicatricial) types.
OBJECTIVE: The aim of this study is to investigate the expression of stem cell (SC) markers such as cytokeratin (CK) 17 and CK19 in scarring and nonscarring alopecia.
MATERIALS AND METHODS: Thirty patients with scalp alopecia (15 with scarring alopecia and 15 without) together with ten healthy volunteers were included in this study. Biopsies were taken from all participants and stained for CK17 and CK19 using immunohistochemistry.
RESULTS: There was a statistically significant difference between the nonscarring group and the control group with regard to CK17 expression in the outer layers of the HFs ( P = 0.00) and CK19 staining of the inner layers of the HFs ( P = 0.008). There was a statistically significant difference between the scarring and the control groups regarding CK17 expression in the outer ( P = 0.00) and the inner layers ( P = 0.00) of the HFs and CK19 expression in the inner layers of the HFs ( P = 0.00). CK17 expression in the outer layers ( P = 0.02) and the inner layers of the HFs ( P = 0.00) together with CK19 expression in the inner layers of the HFs ( P = 0.00) showed statistically significant differences between scarring and nonscarring alopecia groups.
CONCLUSIONS: The presence of SC markers (CK17 and CK19) in the HFs was affected in both scarring and nonscarring alopecia, but the defect in scarring alopecia is more evident than that of nonscarring alopecia. The persistence of SC markers in some types of scarring alopecia could give a hope for the recovery of these lesions. Further studies are recommended to clarify the benefit from using HF SCs in the treatment of alopecia.
OBJECTIVE: The aim of this study is to investigate the expression of stem cell (SC) markers such as cytokeratin (CK) 17 and CK19 in scarring and nonscarring alopecia.
MATERIALS AND METHODS: Thirty patients with scalp alopecia (15 with scarring alopecia and 15 without) together with ten healthy volunteers were included in this study. Biopsies were taken from all participants and stained for CK17 and CK19 using immunohistochemistry.
RESULTS: There was a statistically significant difference between the nonscarring group and the control group with regard to CK17 expression in the outer layers of the HFs ( P = 0.00) and CK19 staining of the inner layers of the HFs ( P = 0.008). There was a statistically significant difference between the scarring and the control groups regarding CK17 expression in the outer ( P = 0.00) and the inner layers ( P = 0.00) of the HFs and CK19 expression in the inner layers of the HFs ( P = 0.00). CK17 expression in the outer layers ( P = 0.02) and the inner layers of the HFs ( P = 0.00) together with CK19 expression in the inner layers of the HFs ( P = 0.00) showed statistically significant differences between scarring and nonscarring alopecia groups.
CONCLUSIONS: The presence of SC markers (CK17 and CK19) in the HFs was affected in both scarring and nonscarring alopecia, but the defect in scarring alopecia is more evident than that of nonscarring alopecia. The persistence of SC markers in some types of scarring alopecia could give a hope for the recovery of these lesions. Further studies are recommended to clarify the benefit from using HF SCs in the treatment of alopecia.
Full text links
Related Resources
Trending Papers
Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows.Endocrine Reviews 2024 April 28
The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association.Circulation 2024 April 26
Intravenous infusion of dexmedetomidine during the surgery to prevent postoperative delirium and postoperative cognitive dysfunction undergoing non-cardiac surgery: a meta-analysis of randomized controlled trials.European Journal of Medical Research 2024 April 19
Interstitial Lung Disease: A Review.JAMA 2024 April 23
Management of Diverticulitis: A Review.JAMA Surgery 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app